Page last updated: 2024-08-22

stanozolol and Interstitial Cell Tumor

stanozolol has been researched along with Interstitial Cell Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andò, S; Catalano, S; Chimento, A; De Luca, A; Lanzino, M; Pezzi, V; Sirianni, R; Zolea, F	1

Other Studies

1 other study(ies) available for stanozolol and Interstitial Cell Tumor

Article	Year
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system. Journal of cellular physiology, 2012, Volume: 227, Issue:5 Topics: Anabolic Agents; Androgens; Animals; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Cell Proliferation; Cyclin E; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Insulin-Like Growth Factor I; Leydig Cell Tumor; Male; Nandrolone; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; Stanozolol; Testicular Neoplasms	2012

Article

Year

Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.

Journal of cellular physiology, 2012, Volume: 227, Issue:5

Topics: Anabolic Agents; Androgens; Animals; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Cell Proliferation; Cyclin E; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Insulin-Like Growth Factor I; Leydig Cell Tumor; Male; Nandrolone; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; Stanozolol; Testicular Neoplasms

2012